Back Stocks profile

Stock analysis tool for investors

Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM | BSE:500420

₹2819.65 38.45 (1.38%) 1D

Pharmaceuticals & Biotechnology

View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

2785.00

Today’s High

2837.00

52W low

1772.00

52W High

2980.00

Open Price

2785.00

Prev. Close

2782.0000

Volume

471206.00

Value

1328635997.90

Fundamentals

Market Cap Cr

95429.80

Price to Earnings

57.60

Price to Book Value

13.90

Dividend Yield

1.00

PE to Growth

1.70

Op Revenue TTM Cr

10728.00

Net Profit TTM Cr

1656.00

Cash From Operating Activity Cr

3266.08

Return on Equity %

24.15

EMA & SMA

Bullish Moving Averages

14

Bearish Moving Averages

2

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

02 Jul, 2024

60.8

Week

65

Month

54.8

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

2813.90

PIVOT

First Resistance

2842.75

Second Resistance

2865.85

Third Resistance

2894.70

First Support

2790.80

Second Support

2761.95

Third Support

2738.85

Relative Strength Index

55.12

Money Flow Index

44.75

MACD

22.92

MACD Signal

36.2

Average True Range

68.98

Average Directional Index

18.4

Rate of Change (21)

4.58

Rate of Change (125)

22.3

Commodity Channel Index

-22.5

Williams %R

-71.6

BETA

1 Month

0.1

3 Month

0.28

1 Year

0.19

3 Year

-0.06

PRICE CHANGE ANALYSIS

-0.38%

1 Week

Low

High

2755.9

2843.2

4.58%

1 Month

Low

High

2570.45

2980

5.66%

3 Months

Low

High

2505.3

2980

21.42%

6 Months

Low

High

2301.6

2980

48.02%

1 Year

Low

High

1772.05

2980

Bigul
01 Jul 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper cuttings in connection with the 51st Annual General Meeting and E-Voting Procedure.
Bigul
29 Jun 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Submission Of The Annual Report For The FY 2023-24 And The Notice Convening 51St Annual General Meeting Of The Company.

Submission of the Annual Report for the FY 2023-24 and the Notice convening 51st AGM of the Company
Bigul
29 Jun 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Business Responsibility and Sustainability Reporting (BRSR)

Submission of the Business Responsibility and Sustainability Report (BRSR) for FY 2023-24 of the Company
Bigul
29 Jun 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Reg. 34 (1) Annual Report.

Submission of Annual Report for FY 2023-24 and intimation of voting through electronic means
Bigul
28 Jun 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Closure of Trading Window

Intimation of the Closure of Trading Window as per Company''s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons
Bigul
25 Jun 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Advertisement - Intimation of the 51st Annual General Meeting of the Company through Video Conferencing / Other Audio Visual Means ("VC / OAVM") facility
Bigul
21 Jun 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Disclosure under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Bigul
13 Jun 2024

Torrent Pharma slips 3% after USFDA issues 5 observations for Indrad Unit

The fall came after the United States Food and Drug Administration (USFDA) issued a Form 483 with five observations for the Indrad unit
See all News

FAQs

The latest market price of Torrent Pharmaceuticals Ltd. on NSE was Rs. 2819.65 as of today.

The opening share price of Torrent Pharmaceuticals Ltd. was Rs. 2785.00 as of today.

The 52-week high share price of Torrent Pharmaceuticals Ltd. was Rs. 2980.00.

The 52 week low share price of Torrent Pharmaceuticals Ltd. was Rs. 1772.00.

Torrent Pharmaceuticals Ltd. has a market cap of Rs. 95429.80 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Torrent Pharmaceuticals Ltd. is 1.70. Please refer to the Fundamentals section for further details.

The operating revenue for Torrent Pharmaceuticals Ltd. in the last FY was Rs.  10728.00 crore. Please refer to the Financials section for further details.

The Net Profit for Torrent Pharmaceuticals Ltd. in the last FY was Rs. 1656.00 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Torrent Pharmaceuticals Ltd. was on 2024-06-21 for Rs. 6 per share. According to today’s share price, the dividend yield of Torrent Pharmaceuticals Ltd. stands at 1.00. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Torrent Pharmaceuticals Ltd. was as of 2022-07-08. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Torrent Pharmaceuticals Ltd. was as of 2006-02-20. The split ratio declared in this issue was 10:5. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Torrent Pharmaceuticals Ltd..

Close

Let's Open Free Demat Account